Leading Cannabis Testing Labs From East and West Coast Markets Unify Brands as BelCosta Labs
LONG BEACH, Calif. — BelCosta Labs, a leading California third-party cannabis testing lab, today announced the company is expanding its operations beyond California. BelCosta is combining businesses with independent testing labs US Cannalytics (“USC”) and Pinnacle CT Labs (“PCT”). USC currently services Florida, New Jersey, and Pennsylvania, and PCT services Maryland. All laboratories will be rebranded and operate as BelCosta Labs.
The merger combines over ten years of cannabis-specific, analytical testing expertise from five different state markets to create a national laboratory group rooted in quality, transparency, and innovation. The new lab group is positioned to lead the evolution of the cannabis testing industry with best-in-class methodologies providing operators, patients, and consumers alike with detailed and accurate data to more effectively understand the cannabis experience.
“We are thrilled to be expanding our business out of state for the first time since starting BelCosta in 2017,” said Myron Ronay, CEO of BelCosta Labs. “As one of the oldest testing labs in a mature market like California, we are eager to join forces with the U.S. Cannalytics team to provide cannabis producers across the country with high-quality testing services and insight.”
Founded in 2018, USC and PCT are a multi-state group of independent testing laboratories servicing medical and recreational cannabis and hemp/CBD markets. As one of the largest cannabis testing organizations on the East Coast with over seventy-five years of combined management experience across medical, pharmaceutical, and other professional fields, USC and PCT have emerged as leaders in the East Coast markets.
PCT is dedicated to ensuring a safe supply for medical cannabis patients in Maryland. PCT’s scientific team includes professionals with over 30 years of combined experience in their respective fields.
“We are excited to join BelCosta Labs and to work collaboratively with a great team to advance the cannabis testing industry,” said Karrissa Miller, Director of Client Services for USC and PCT. “USC and PCT pride ourselves on our highly skilled team’s vast experience and knowledge; joining BelCosta enhances our ability to exceed minimum regulatory and quality requirements for our current and future customer base.”
BelCosta Labs aims to use the latest analytic methods, customized technology and its staff of nationally renowned experts to provide top-quality compliance testing services for the cannabis industry.
About BelCosta Labs
BelCosta Labs is leading the evolution of cannabis lab testing through agricultural science, education, and technology. Combining analytic methods, customized technology, and years of expertise in the cannabis industry to provide the highest quality testing lab services for compliance. BelCosta Labs is a member of the American Council of Independent Laboratories (ACIL) Cannabis Working Group, ISO-accredited by the American Association for Laboratory Accreditation (A2LA), and Patient Focus Certified by Americans for Safe Access (ASA). Our staff comprises nationally renowned agricultural science experts, who have set the standard for accurate testing methods and are committed to providing the best testing lab services and pushing the boundaries of agricultural science and research.
About US Cannalytics and Pinnacle CT Labs
US Cannalytics, LLC and Pinnacle CT Labs are a multi-state group of independent testing laboratories servicing medical marijuana/medical cannabis and hemp/CBD markets in MD, PA, FL and NJ. Currently, one of the largest privately owned independent cannabis testing organizations on the East Coast, US Cannalytics and Pinnacle CT Labs provide world-class testing and services to our partners. With over seventy-five years of combined management experience across medical, pharmaceutical, and other professional fields, US Cannalytics and Pinnacle CT Labs leverages their vast experience and knowledge to exceed minimum regulatory, technical, and quality requirements.
Our core principles revolve around consistently producing high-quality results, using robust methods and processes, and nurturing genuine relationships within the cannabis industry and regulatory bodies. We are proud to provide the superior feedback necessary to produce market-leading products and ensure patient and consumer transparency and safety within the marketplace.
Subject to Regulatory Approval. The obligations of the parties hereunder are subject to all required regulatory approvals of each state regulatory body.
- Minority Cannabis Academy: Social Equity in Practice
The Minority Cannabis Academy graduated its first class of 25 students in September. The Academy’s goal is to take advantage of the social equity atmosphere in New Jersey to help those most harmed by prohibition. - Marijuana Policy Project Releases Voter Guide to 2022 Governors’ Races and Cannabis Policy Reform Ahead of Midterm Election
On Tuesday, the Marijuana Policy Project (MPP) released their voter guide to 2022 governors’ races and cannabis policy reform. In 36 states, voters will be choosing their next governor on Election Day. - Green Thumb to Launch “RISE Express” Dispensaries in Florida
Green Thumb Industries Inc., a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced plans to expand its medical retail footprint in Florida through a lease agreement with Circle K, the global convenience store retailer. - Missouri AFL-CIO endorses cannabis legalization constitutional amendment
Missouri AFL-CIO president Jake Hummel on Thursday announced his organization was endorsing the proposal, which will appear on the Nov. 8 ballot as Amendment 3, calling it a “huge step forward for criminal justice reform in Missouri.” - Minnesota’s Black cannabis users far more likely to face arrest than white ones
Black Minnesotans are nearly five times as likely to be arrested on marijuana charges as white ones, according to the latest data from the Bureau of Criminal Apprehension. It’s a disparity that has persisted for years, despite data showing that Black and white residents use cannabis at similar rates. - Lawmakers ask MO governor to add cannabis legalization in special session
A bipartisan group of lawmakers and activists are calling for Missouri Gov. Mike Parson to include marijuana legalization on the agenda of the legislature’s upcoming special session. - In Brief: Pa. Governor Accepting Cannabis Pardon Requests in Sept.
Pennsylvania Gov. Tom Wolf and Lt. Gov. John Fetterman announce the PA Marijuana Pardon Program, offering expedited pardon reviews to people convicted of only minor cannabis possession for personal use. - Michigan State Police stops cannabis testing after false positives
Michigan State Police have acknowledged that its blood tests for marijuana are producing false positives for THC, and it will immediately halt testing. - Missouri Dems expect boost from cannabis, but split on specifics
Support for legalization and heartburn about the amendment’s details have led to soul-searching among Democratic Party officials across the state. The consternation is particularly acute among Black Democratic leaders. - Signatures on Nebraska medical cannabis petitions to get another look
The Nebraska Secretary of State’s Office has agreed to take another look at signatures submitted by a group seeking legalization of medical marijuana to determine if they should have been counted.